TITLE

Leukocytosis and Clostridium difficile-Associated Diarrhea

AUTHOR(S)
Bartlett, John G.
PUB. DATE
November 2000
SOURCE
American Journal of Gastroenterology;Nov2000, Vol. 95 Issue 11, p3023
SOURCE TYPE
Academic Journal
DOC. TYPE
Editorial
ABSTRACT
Provides information on leukocytosis and Clostridium difficile-associated diarrhea. Information on Clostridium difficile (C. difficile) testing; Ways that an antibiotic associated diarrhea laboratory finding can assist a practitioner; Use of hypoalbuminemia.
ACCESSION #
17628198

 

Related Articles

  • Fluoroquinolone Use and Clostridium difficile-associated Diarrhea. McCusker, Margaret E.; Harris, Anthony D.; Perencevich, Eli; Roghmann, Mary-Claire // Emerging Infectious Diseases;Jun2003, Vol. 9 Issue 6, p730 

    Focuses on a case-control study which evaluated the association between antibiotic use and Clostridium difficile-associated diarrhea (CDAD). Characteristics of CDAD cases and matched controls; Risks factors for CDAD; Association between fluoroquinolones and CDAD.

  • Clostridium difficile-associated diarrhoea (CDAD): new and contentious issues. GOULIOURIS, THEODOROS; FORSYTH, DUNCAN R.; BROWN, NICHOLAS M. // Age & Ageing;Sep2009, Vol. 38 Issue 5, p497 

    The article offers information on clostridium difficile-associated diarrhoea (CDAD). The current strategies for the prevention of the disease are discussed. Recent American and British treatment recommendation for CDAD emphasise the importance assessing the severity of the disease to stratify...

  • Stability and Recovery of DIFICID (Fidaxomicin) 200-mg Crushed Tablet Preparations from Three Delivery Vehicles, and Administration of an Aqueous Dispersion via Nasogastric Tube. Tousseeva, Anna; Jackson, J.; Redell, Mark; Henry, Teresa; Hui, Michael; Capurso, Shelley; DeRyke, C. // Drugs in R&D;Dec2014, Vol. 14 Issue 4, p309 

    Fidaxomicin is approved for the treatment of adults with Clostridium difficile-associated diarrhea, many of whom have difficulty swallowing an intact tablet. The study objective was to evaluate the stability and recovery of crushed DIFICID (fidaxomicin) 200-mg tablets dispersed in water,...

  • Similar Frequency of Detection of Clostridium perfringens Enterotoxin and Clostridium difficile Toxins in Patients with Antibiotic-Associated Diarrhea. Abrahao, C.; Carman, R.; Hahn, H.; Liesenfeld, O. // European Journal of Clinical Microbiology & Infectious Diseases;Sep2001, Vol. 20 Issue 9, p676 

    The article investigates the prevalence of CPEnt in stool samples submitted for detection of Clostridium difficile toxins. Antibiotic-associated diarrhea (AAD) continues to be a major nosocomial health problem. Clostridium difficile toxins can be detected in 10-25% of patients with AAD, but no...

  • Clostridium difficile infection in hospitals: a brewing storm. Valiquette, Louis; Low, Donald E.; P├ępin, Jacques; McGeer, Allison // CMAJ: Canadian Medical Association Journal;7/6/2004, Vol. 171 Issue 1, p27 

    Discusses research being done on Clostridium difficile-associated diarrhea (CDAD). Reference to a study by L. Eggertson and B. Sibbald, published in the June 4, 2004 issue of the "Canadian Medical Association Journal"; Estimated incidence of CDAD in Canada; Factors contributing to the incidence...

  • A Predictive Model to Identify Clostridium difficile Toxin in Hospitalized Patients with Diarrhea. Cooper, Gregory S.; Lederman, Michael M.; Salata, Robert A. // American Journal of Gastroenterology;Jan1996, Vol. 91 Issue 1, p80 

    Objectives: Although Clostridium difficile is a common pathogen in hospitalized patients with diarrhea, no study has attempted to develop a predictive model to estimate the likelihood of C. difficile positivity. Methods: We conducted a cross-sectional study at a single hospital...

  • Clostridium difficile Toxin Associated with Chronic Diarrhea and Failure to Gain Weight. Liston, Thomas E. // Clinical Pediatrics;Jun1983, Vol. 22 Issue 6, p458 

    Two young children are described in whom chronic diarrhea associated with the presence of Clostridium difficile toxin responded to treatment with oral vane comycin. C. difficile infection should be considered in the evaluation of young children with diarrhea who fail to gain weight, even in the...

  • Probiotics Helped Prevent Antibiotic-Associated Diarrhea. D'souza, A. L.; Rajkumar, C.; Cooke, J.; Bulpitt, C. J. // Annals of Internal Medicine;9/7/2004, Vol. 141 Issue 5, p378 

    This article reports that probiotics helps in preventing antibiotic-associated diarrhea. Health food stores are stocked with heavily advertised probiotics, which are mixtures of microorganisms. Since antibiotic-associated diarrhea is a common problem due to overgrowth with Clostridium difficile,...

  • Evaluation of Antibiotic-Associated Diarrhea with a Latex Agglutination Test and Cell Culture Cytotoxicity Assay for Clostridium difficile. Biddle, Wendy L.; Harms, Jane L.; Greenberger, Norton J.; Miner Jr., Philip B. // American Journal of Gastroenterology;Apr1989, Vol. 84 Issue 4, p379 

    Diagnosis of Clostridium difficile (C. difficile) by its antigen or toxin has improved treatment for patients who have antibiotic-associated diarrhea and opportunistic colonization of the colon with C. difficile. Unfortunately, results from the tissue culture cytotoxicity assay...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics